Ann Moyer, M.D., Ph.D., Makes a Case for Pharmacogenomics - Insights
Pharmacogenomic testing is still limited, despite ample research, the existence of guidelines, and the emerging evidence it can help patients. Ann Moyer, M.D., Ph.D., Co-Director of the Personalized Genomics Laboratory at Mayo Clinic in...
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.
Week in Review: November 8 - Insights
Top highlights include: Discovery of a new HIV strain, Google to acquire Fitbit, how to stay healthy while traveling during the holidays, and how a rare mutation protected a woman from developing Alzheimer's.
People Archives - Page 35 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
According to Mayo Clinic research published in JAMA, six genes contain mutations that may be passed down in families, substantially increasing a person’s risk for pancreatic cancer.
Mayo Clinic Laboratory and Pathology Research Roundup: June 25 - Insights
This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.
Mayo Clinic Laboratory and Pathology Research Roundup: Jan. 15 - Insights
This week’s Research Roundup highlights how the loss of FOXO1 cooperates with TMPRSS2-ERG overexpression to promote prostate tumorigenesis and cell invasion.
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 4 - Insights
This week’s Research Roundup highlights individual patient-level meta-analysis of the performance of the Decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease.
Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 21 - Insights
This week’s Research Roundup highlights how intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.
Mayo Clinic Discovers Biological Markers That Could Guide Treatment for Prostate Cancer - Insights
Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbor higher-risk cancer in their prostate glands, Mayo Clinic has discovered.